If you are in remission after three rounds of chemotherapy for AML with an FLT3 mutation and cannot have a bone marrow transplant, the next step typically involves post-remission therapy. This is also known as consolidation or maintenance therapy. The goal of this phase is to destroy any remaining leukemia cells that Show Full Answer

If you are in remission after three rounds of chemotherapy for AML with an FLT3 mutation and cannot have a bone marrow transplant, the next step typically involves post-remission therapy. This is also known as consolidation or maintenance therapy. The goal of this phase is to destroy any remaining leukemia cells that survived the initial treatment to prevent relapse.

Here are the key points:

- Post-Remission Therapy: This phase is designed to eliminate any residual leukemia cells.
- Consolidation Therapy: This involves additional cycles of chemotherapy to ensure no leukemia cells remain.
- Maintenance Therapy: This may include lower doses of medication over a longer period to maintain remission.

Each person's treatment plan will depend on their specific situation, including the risk of leukemia returning and other health factors.

 This AI-generated response comes from MyLeukemiaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Acute Myeloid Leukemia Treatment Options | MyLeukemiaTeam

Acute Myeloid Leukemia: Your Guide | MyLeukemiaTeam